Zanoni BC, et al. BMJ Glob Health 2016;1:e000004. doi:10.1136/bmjgh-2015-000004
Child Survival Working Group
Accessed: 18.10.2019
WHO
Considering programmatic implications of rising levels of HIV drug resistance: finalizing the Global Action Plan
Webinars 12 13 Dec 2016
Policy Brief
published: 16 March 2018 doi: 10.3389/fpubh.2018.00069
J Hepatol (2017), http://dx.doi.org/10.1016/j.jhep.2017.03.021
World Aids Day, 1. December 2018
Commemorating 30 Years
Accessed: 05.10.2019
The evidence base for differentiated care for stable patients has grown in recent years. There has been less attention, however, to developing differentiated models of care for patients with advanced or unstable HIV disease. Current clinical guidelines and policies regarding optimal packages of care... for high-risk patients give few or no recommendations about how, by whom, or where they should be delivered for optimal impact.
more
HIV Treatment
Policy Brief
July 2017
Locate, test, treat and retain (L2TR) Ghana campaign. 90-90-90 ending the AIDS epedemic by 2030
Bain LE, et al. BMJ Glob Health 2017;2:e000227. doi:10.1136/bmjgh-2016-000227
WHO/UNAIDS 2017 | Statement
This progress report reviews recent gains, new developments and remaining challenges as countries approach the 2020 targets of the Start Free Stay Free AIDS Free framework.
Almost half (46%) of the world’s 1.7 million children living with HIV were not on treatment in 2020 and 150 000 children were newly infected with HIV, four times more than the 2020 target of 40 000